Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B

Drug Development and Industrial Pharmacy

Volumn 41, Issue 5, 2015, Pages 780-790

  Hussain, Afzal ^a   Samad, Abdus ^b   Singh, Sandeep Kumar ^a   Ahsan, Mohd Neyaz ^a   Faruk, Abdul ^c   Ahmed, Farhan Jalees ^d  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b Panacea Biotec Ltd   (India)

^c H N B GARHWAL UNIVERSITY   (India)

^d HAMDARD UNIVERSITY   (India)

Author keywords

Amphotericin B; Enhanced skin permeation; Nanoemulsion; Topical drug delivery

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; OIL; SEFSOL 218 OIL; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; CAPRYOL PROPYLENE GLYCOL MONOCAPRYLATE; DRUG CARRIER; EMULSION; NANOPARTICLE; POLYMER; PROPANEDIOL DERIVATIVE;

ALBINO RAT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUTION; DRUG STABILITY; EX VIVO STUDY; NANOEMULSION; NONHUMAN; OPTICAL DENSITY; PARTICLE SIZE; PH; RAT; SHELF LIFE; SKIN PENETRATION; STORAGE TEMPERATURE; TEMPERATURE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; CONFOCAL MICROSCOPY; CUTANEOUS DRUG ADMINISTRATION; DRUG STORAGE; EMULSION; FEMALE; MALE; MEDICINAL CHEMISTRY; PROCEDURES; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; EMULSIONS; FEMALE; HYDROGEN-ION CONCENTRATION; MALE; MICROSCOPY, CONFOCAL; NANOPARTICLES; POLYMERS; PROPYLENE GLYCOLS; RATS; SKIN ABSORPTION; TEMPERATURE;

EID: 84930365509     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.902957     Document Type: Article

References (38)

1. Kleinberg M. What is the current and future status of conventional amphotericin B? Int J Antimicrob Agents 2006;27:S12-16.
2. Nahar M, Mishra D, Dubey V, et al. Development, characterization and toxicity evaluation of amphotericin B-loaded gelatin nanopar-ticles. Nanomedicine NBM 2008;4:252-61.
3. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 1998;27:603-18.
4. Barwicz J, Christian S, Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother 1992;36:2310-15.
5. Bau P, Bolard J, Dupouy-Camet J. Heated amphotericin to treat leishmaniasis. Lancet Infect Dis 2003;3:188.
6. Brajtburg J, Bolard J. Carrier effects on biological activity of amphotericin B. Clin Microb Rev 1996;9:512-31.
7. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, et al. The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005;291:79-86.
8. Sarbolouki MN, Toliat T. Storage stability of stabilized MLV and REV liposomes containing sodium methotrexate (aqueous & lyophilized). PDA J Pharm Sci Technol 1998;52:23-7.
9. Brandl M. Liposomes as drug carriers:a technological approach. Biotechnol Annu Rev 2001;7:59-85.
10. Shafiq S, Shakeel F. Enhanced stability of ramipril in nanoemulsion containing cremophor-EL: a technical note. AAPS Pharm Sci Tech 2008;9:1097-101.
11. Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007;66:227-42.
12. Formariz TP, Urban MCC, Da Silva Júnior AA, et al. Nanoemulsions and liquid crystalline phases as drug delivery systems. Braz J Pharm Sci 2005;41:301-13.
13. Formariz TP, Sarmento VHV, Silvajunior AA, et al. Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine. Colloids Surf B Biointerfaces 2006;51:54-61.
14. Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS Pharm Sci Tech 2009;10:69-76.
15. Lemke A, Kiderlen AF, Petri B, et al. Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas. Nanomedicine 2010;6:597-603.
16. Jung SH, Lim DH, Jung SH, et al. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci 2009;37:313-20.
17. Utreja P, Jain S, Tiwary AK. Localized delivery of paclitaxel using elastic lipospmes formulation development and evaluation. Drug Deliv 2011;18:367-76.
18. Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123:148-54.
19. Chaix C, Pacard E, Eläissari A, et al. Surface functionalization of oil in water nanoemulsion with a reactive copolymer: colloidal characterization and peptide immobilization. Colloids Surf B2003;29: 39-52.
20. Windholz M, Budavari S, Blumetti R, et al. Amphothericin B. The Merck index. New York: Merck; 1983.
21. Bennett J. Antimicrobial agents:antifungal agents. In: Hardman J, Limbird L, eds. Goodman & Gilman's pharmacological basis of therapeutics. New York: McGraw-Hill; 1995:1175-90.
22. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm Res 1995;12:1561-72.
23. Godwin DA, Michniak BB, Creek KE. Evaluation of transdermal penetration enhancers using a novel skin alternative. J Pharm Sci 1997;86:1001-5.
24. Shin SC, Choi JS. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats. Eur J Pharm Biopharm 2005;61:14-19.
25. Gosh PK, Murthy RSR. Microemulsions: a potential drug delivery system. Curr Drug Deliv 2006;3:167-80.
26. Reddy LH, Ghosh B. Enhancer aided in vitro permeation of atenolol and prazosin hydro-chloride through mice skin. Indian J Exp Biol 2001;39:47-51.
27. Vandermeulen G, Rouxhet L, Arien A, et al. Encapsulation of amphotericin B in poly (ethylene glycol)-block-poly("-caprolactone-co-trimethylene carbonate) polymeric micelles. Int J Pharm 2006; 309:234-40.
28. Gehring W, Gehse M, Zimmermann V, Gloor M. Effects of ph changes in a specific detergent multicomponent emulsion on the water content of stratum corneum. J Sos Cosmet Chem 1991;42: 327-33.
29. Knor T, Meholjić-Fetahović A, Mehmedagić A. Stratum corneum hydration and skin pH in patients with Atopic Dermatitis. Acta Dermatovenerol Croat 2011;19:242-7.
30. Mourtas S, Fotopoulou S, Duraj S, Sfika V, Tsakiroglou C, Antimisiaris, SG. Liposomal drugs dispersed in hydrogels:effect of liposome, drug and gel properties on drug release kinetics. Colloids Surf B2007;55:212-21.
31. Legrand P, Romero E, Devissaguet JP, et al. Effects of aggregation and solvent on toxicity of amphotericin B to human erythrocytes. Antimicrob Agents Chemother 1992;36:2518-22.
32. Aramwit P, Yu BG, Lavasanifar A, et al. The effect of serum albumin on the aggregation state and toxicity of amphotericin B. J Pharm Sci 2000;89:1589-93.
33. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110: 296-306.
34. Potts OR, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991;96: 495-9.
35. Borgia SL, Regehly M, Sivaramakrishnan R, et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005; 110:151-63.
36. Hu FQ, Jiang SP, Du YZ, et al. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 2006;314: 83-9.
37. Potts OR, Francoeur ML. The influence of stratum corneum morphology on water permeability. Invest Dermatol 1999;96:495-9.
38. Zhao Y, Wang CG, Chowb AHL, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of zedoary essential oil: formulation and bioavailability studies. Int J Pharm 2010;383:170-7.